Treatment of early aggressive rheumatoid arthritis (TEAR)

Trial Profile

Treatment of early aggressive rheumatoid arthritis (TEAR)

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Nov 2015

At a glance

  • Drugs Etanercept (Primary) ; Hydroxychloroquine (Primary) ; Methotrexate (Primary) ; Sulfasalazine (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms TEAR
  • Most Recent Events

    • 25 Nov 2015 Results (assessing long term changes in cholesterol levels) published in the Arthritis and Rheumatology (n = 416).
    • 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
    • 16 Jun 2010 Results were presented at the 11th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top